More than structural cells, fibroblasts create and orchestrate the tumor microenvironment

被引:85
作者
Baglole, Carolyn J.
Ray, Denise M.
Bernstein, Steven H.
Feldon, Steven E.
Smith, Terry J.
Sime, Patricia J.
Phipps, Richard P.
机构
[1] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Ophthalmol, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, Rochester, NY 14642 USA
[4] Univ Rochester, Sch Med & Dent, Div Pulm & Crit Care Med, Rochester, NY 14642 USA
[5] James P Wilmot Canc Ctr, Lymphoma Biol Program, Rochester, NY USA
[6] Univ Calif Los Angeles, Harbor Med Ctr, Div Mol Med, Torrance, CA 90509 USA
关键词
cancer; cyclooxygenase; fibroblast; inflammation; Thy-1;
D O I
10.1080/08820130600754960
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The tumor microenvironment comprises many cell types including infiltrating immune cells such as lymphocytes, endothelial cells and a complex stroma consisting mainly of fibroblasts. Fibroblasts are heterogeneous and consist of Thy-1(+) and Thy-1(-) subsets that define different biosynthetic and differentiation potential. They produce mediators linked to carcinogenesis and metastasis, including Cox-2 and PGE(2), both of which are also increased in most cancers. This review will highlight the emerging role of the complex fibroblastic stroma in establishing a microenvironment supporting malignant transformation, tumor growth and attenuation of host anti-tumor immune responses.
引用
收藏
页码:297 / 325
页数:29
相关论文
共 172 条
[11]   In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas [J].
Bell, D ;
Chomarat, P ;
Broyles, D ;
Netto, G ;
Harb, GM ;
Lebecque, S ;
Valladeau, J ;
Davoust, J ;
Palucka, KA ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1417-1425
[12]  
Bellocq A, 1998, AM J PATHOL, V152, P83
[13]  
Bhardwaj B, 1996, CLIN CANCER RES, V2, P773
[14]   Stromal fibroblasts in cancer initiation and progression [J].
Bhowmick, NA ;
Neilson, EG ;
Moses, HL .
NATURE, 2004, 432 (7015) :332-337
[15]   TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia [J].
Bhowmick, NA ;
Chytil, A ;
Plieth, D ;
Gorska, AE ;
Dumont, N ;
Shappell, S ;
Washington, MK ;
Neilson, EG ;
Moses, HL .
SCIENCE, 2004, 303 (5659) :848-851
[16]   The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [J].
Bingle, L ;
Brown, NJ ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :254-265
[17]   Regulation of PDGF and its receptors in fibrotic diseases [J].
Bonner, JC .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) :255-273
[18]  
BORDIN S, 1983, J IMMUNOL, V130, P1871
[19]   Differential Thy-1 expression by splenic fibroblasts defines functionally distinct subsets [J].
Borrello, MA ;
Phipps, RP .
CELLULAR IMMUNOLOGY, 1996, 173 (02) :198-206
[20]  
Bourhis XFDL, 1997, INT J CANCER, V71, P42, DOI 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.3.CO